NEW YORK and LONDON, December 2, 2014
Celsus Therapeutics (NASDAQ: CLTX), an emerging growth, development-stage biopharmaceutical company, announces that Gur Roshwalb, MD, chief executive officer, is scheduled to present at the Oppenheimer 25th Annual Healthcare Conference at Crowne Plaza Hotel in New York City.
